Clinical Trials Logo

Clinical Trial Summary

A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Voriconazole(200mg/Vial) After Intravenous Infusion of 200mg Voriconazole in Healthy Volunteers Under Fasting Conditions.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04552353
Study type Interventional
Source Yung Shin Pharm. Ind. Co., Ltd.
Status Completed
Phase Phase 4
Start date June 13, 2020
Completion date June 21, 2020